Clinical Efficacy of Glutamine Combined with Erythropoietin in the Treatment of Necrotizing Enterocolitis in Premature Infants and Its Effect on Serum IL-6 TNF-α and i-FABP Levels
Objective:To investigate the clinical efficacy of glutamine combined with erythropoietin in the treatment of necrotizing enterocolitis(NEC)in premature infants and its effect on serum IL-6,TNF-α,and i-FABP levels.Methods:A retrospective analysis was conducted on 100 premature infants diagnosed with NEC in the Department of Neonatology,The First Affiliated Hospital of China Medical University from January 2020 to January 2022.According to the treatment methods received by the infants,they were divided into the observation group(n=50)and the control group(n=50).The observation group was treated with glutamine combined with erythropoietin,and the control group was treated with glutamine alone.The total effective rate,inflammatory reaction,i-FABP,immunoglobulin level,intestinal flora change,and drug safety of the two groups were recorded and observed.Results:The total effective rate of the observation group(92.00%)was significantly higher than that of the control group(70.00%),and the difference was statistically significant(P<0.05).Before treatment,there was no statistically significant difference in the levels of serum inflamma-tory factors,i-FABP,IgA,IgM,IgG,and the total number of bacteria,cocci,and bacilli in the stool speci-mens between the two groups(P>0.05).Compared with before treatment,the levels of serum IL-6,TNF-α and i-FABP in both groups decreased after 7 days of treatment,and the levels of IgA,IgM,IgG,the total number of bacteria,cocci,and bacilli in the stool specimens increased.The differences were statistically sig-nificant(P<0.05).There was a statistically significant difference in the changes of serum IL-6,TNF-α,i-FABP,IgA,IgM,IgG levels,and the total number of bacteria,cocci,and bacilli in the stool specimens be-fore and after treatment between the two groups(P<0.05).During the one-month follow-up,there was no statistically significant difference in the adverse reactions between the two groups(P>0.05).Conclusion:On the basis of glutamine,combined erythropoietin can effectively improve the clinical efficacy of NEC in prema-ture infants,reduce the levels of serum inflammatory factors and i-FABP,promote the stability of intestinal flora in premature infants,enhance the immunity of infants,and has a high safety.
万方数据
维普
